| Association analysis identifies 65 new breast cancer risk loci K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ... Nature 551 (7678), 92-94, 2017 | 1314 | 2017 |
| Polygenic risk scores for prediction of breast cancer and breast cancer subtypes N Mavaddat, K Michailidou, J Dennis, M Lush, L Fachal, A Lee, JP Tyrer, ... The American Journal of Human Genetics 104 (1), 21-34, 2019 | 899 | 2019 |
| Prediction of breast cancer risk based on profiling with common genetic variants N Mavaddat, PDP Pharoah, K Michailidou, J Tyrer, MN Brook, MK Bolla, ... Journal of the National Cancer Institute 107 (5), djv036, 2015 | 670 | 2015 |
| Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer K Michailidou, J Beesley, S Lindstrom, S Canisius, J Dennis, MJ Lush, ... Nature genetics 47 (4), 373-380, 2015 | 649 | 2015 |
| Breast cancer risk genes—association analysis in more than 113,000 women Breast Cancer Association Consortium New England Journal of Medicine 384 (5), 428-439, 2021 | 617 | 2021 |
| Mammographic density phenotypes and risk of breast cancer: a meta-analysis A Pettersson, RE Graff, G Ursin, I dos Santos Silva, V McCormack, ... Journal of the National Cancer Institute 106 (5), dju078, 2014 | 388 | 2014 |
| Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer RL Milne, KB Kuchenbaecker, K Michailidou, J Beesley, S Kar, ... Nature genetics 49 (12), 1767-1778, 2017 | 354 | 2017 |
| PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS MC Southey, DE Goldgar, R Winqvist, K Pylkäs, F Couch, M Tischkowitz, ... Journal of medical genetics 53 (12), 800-811, 2016 | 238 | 2016 |
| A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer L Wu, W Shi, J Long, X Guo, K Michailidou, J Beesley, MK Bolla, XO Shu, ... Nature genetics 50 (7), 968-978, 2018 | 213 | 2018 |
| Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes L Fachal, H Aschard, J Beesley, DR Barnes, J Allen, S Kar, KA Pooley, ... Nature genetics 52 (1), 56-73, 2020 | 149 | 2020 |
| Height and breast cancer risk: evidence from prospective studies and Mendelian randomization B Zhang, XO Shu, RJ Delahanty, C Zeng, K Michailidou, MK Bolla, ... Journal of the National Cancer Institute 107 (11), djv219, 2015 | 146 | 2015 |
| Risk factors and tumor characteristics of interval cancers by mammographic density J Holm, K Humphreys, J Li, A Ploner, A Cheddad, M Eriksson, S Törnberg, ... Journal of Clinical Oncology 33 (9), 1030-1037, 2015 | 144 | 2015 |
| No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing DF Easton, F Lesueur, B Decker, K Michailidou, J Li, J Allen, C Luccarini, ... Journal of medical genetics 53 (5), 298-309, 2016 | 134 | 2016 |
| Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation M Ghoussaini, SL Edwards, K Michailidou, S Nord, R Cowper-Sal· lari, ... Nature communications 5 (1), 4999, 2014 | 133 | 2014 |
| Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer MA Ferreira, ER Gamazon, F Al-Ejeh, K Aittomäki, IL Andrulis, ... Nature communications 10 (1), 1741, 2019 | 121 | 2019 |
| Cohort profile: the Karolinska mammography project for risk prediction of breast cancer (KARMA) M Gabrielson, M Eriksson, M Hammarström, S Borgquist, K Leifland, ... International journal of epidemiology 46 (6), 1740-1741g, 2017 | 120 | 2017 |
| Assessment of breast cancer risk factors reveals subtype heterogeneity J Holm, L Eriksson, A Ploner, M Eriksson, M Rantalainen, J Li, P Hall, ... Cancer research 77 (13), 3708-3717, 2017 | 118 | 2017 |
| A minimum data set for sharing biobank samples, information, and data: MIABIS L Norlin, MN Fransson, M Eriksson, R Merino-Martinez, M Anderberg, ... Biopreservation and biobanking 10 (4), 343-348, 2012 | 117 | 2012 |
| A clinical model for identifying the short-term risk of breast cancer M Eriksson, K Czene, Y Pawitan, K Leifland, H Darabi, P Hall Breast Cancer Research 19, 1-8, 2017 | 112 | 2017 |
| Predictors of discontinuation of adjuvant hormone therapy in patients with breast cancer W He, F Fang, C Varnum, M Eriksson, P Hall, K Czene Journal of Clinical Oncology 33 (20), 2262-2269, 2015 | 105 | 2015 |
Per HallKarolinska InstitutetAdresă de e-mail confirmată pe ki.se
